• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides

Introduction to N-4-(butan-2-yl)phenyl-2-chloropropanamide (CAS No. 731011-88-4)

N-4-(butan-2-yl)phenyl-2-chloropropanamide, a compound with the chemical identifier CAS No. 731011-88-4, is a molecule of significant interest in the field of pharmaceutical chemistry. This compound belongs to the class of amides, characterized by the presence of a carbonyl group bonded to a nitrogen atom. The structural features of N-4-(butan-2-yl)phenyl-2-chloropropanamide make it a versatile intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and inflammatory pathways.

The molecular structure of N-4-(butan-2-yl)phenyl-2-chloropropanamide consists of a phenyl ring substituted at the 4-position with a butan-2-yl group, and an amide linkage connected to a 2-chloropropanamide moiety. This specific arrangement imparts unique electronic and steric properties to the molecule, which are critical for its biological activity. The phenyl ring is known for its ability to interact with aromatic binding sites in proteins, while the amide group can participate in hydrogen bonding interactions, enhancing binding affinity.

In recent years, there has been growing interest in the development of novel compounds that modulate neurological functions. N-4-(butan-2-yl)phenyl-2-chloropropanamide has emerged as a promising candidate in this area due to its potential to interact with specific neurotransmitter receptors and ion channels. Studies have indicated that this compound may exhibit properties similar to those of known pharmacological agents used in the treatment of cognitive disorders and neurodegenerative diseases.

One of the most compelling aspects of N-4-(butan-2-yl)phenyl-2-chloropropanamide is its role as a key intermediate in the synthesis of more complex molecules. Researchers have leveraged its structural framework to develop derivatives with enhanced pharmacological profiles. For instance, modifications at the butan-2-yl group have been explored to optimize solubility and metabolic stability, while alterations at the chloropropanamide moiety have aimed at improving target specificity.

The synthesis of N-4-(butan-2-yl)phenyl-2-chloropropanamide involves multi-step organic reactions, typically starting from commercially available precursors such as 4-bromobenzophenone and butyraldehyde. The process often includes condensation reactions followed by chlorination and amidation steps to achieve the desired product. Advanced synthetic techniques, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to improve yield and purity.

Recent advancements in computational chemistry have also contributed to the understanding of N-4-(butan-2-yl)phenyl-2-chloropropanamide's behavior. Molecular modeling studies have provided insights into its binding interactions with biological targets, helping researchers design more effective derivatives. These computational approaches are complemented by experimental validations, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, which offer detailed structural information.

The pharmacological evaluation of N-4-(butan-2-yl)phenyl-2-chloropropanamide has revealed several interesting properties. In vitro assays have demonstrated its ability to modulate the activity of enzymes involved in neurotransmitter synthesis and degradation. Additionally, preclinical studies suggest that this compound may exhibit anti-inflammatory effects by interacting with cytokine signaling pathways. These findings make it a valuable scaffold for developing novel therapeutic agents.

From a regulatory perspective, N-4-(butan-2-y1)phenyl--(ch1oropropamid~e is classified as an industrial chemical rather than a pharmaceutical product under current guidelines. However, its potential applications in drug development necessitate rigorous safety evaluations before it can be used in clinical settings. Toxicological studies are being conducted to assess its acute and chronic toxicity profiles, as well as potential side effects.

The future prospects for N--(bu-ta-n--y1)-ph~nyl--(ch1oropropamid~e are promising, particularly in the context of personalized medicine. By understanding individual genetic variations that influence drug metabolism and response, researchers can tailor derivatives of this compound to meet specific therapeutic needs. Furthermore, ongoing research into new synthetic methodologies may lead to more efficient production processes, reducing costs and increasing accessibility.

In conclusion, N--(bu-ta-n--y1)-ph~nyl--(ch1oropropamid~e (CAS No. 731011--88--4) represents an important advancement in pharmaceutical chemistry. Its unique structural features and biological activities make it a valuable tool for developing novel therapeutic agents targeting neurological and inflammatory disorders. As research continues to uncover new applications for this compound, it is likely to play an increasingly significant role in drug discovery and development efforts worldwide.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)